Skip to main content
Veterinary Medicines

Vidalta 10 mg prolonged-release tablets for cats

Not authorised
  • Carbimazole

Product identification

Medicine name:
Vidalta 10 mg prolonged-release tablets for cats
VIDALTA 10 mg COMPRIMIDOS DE LIBERACION PROLONGADA PARA GATOS
Active substance:
  • Carbimazole
Target species:
  • Cat
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Carbimazole
    10.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QH03BB01
Authorisation status:
  • Surrendered
Authorised in:
  • Spain
Package description:
  • High density polyethylene container of 100 tablets closed with polypropylene tamper-evident, child-resistant, screw cap bearing a desiccant.
  • High density polyethylene container of 30 tablets closed with polypropylene tamper-evident, child-resistant, screw cap bearing a desiccant.

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Merck Sharp & Dohme Animal Health S.L.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet Ges.m.b.H.
Responsible authority:
  • The Spanish Agency Of Medicines And Medical Devices
Authorisation number:
  • 2470 ESP
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0442/001

Documents

Summary of Product Characteristics

English (PDF)
Published on: 11/02/2022
Download
Spanish (PDF)
Published on: 15/03/2023

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 15/03/2023

Labelling

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 15/03/2023
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."